Brind.

UBS raised its price target for Lifestance Health following the company's strong earnings.

1 report, 1 independent Updated Aug 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

UBS raised its price target for Lifestance Health following the company's strong earnings.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Insider MonkeyUBS Raised the Firm’s PT on LifeStance Health Group (LFST), Kept a Buy Rating LifeStance Health Group, Inc. (NASDAQ:LFST) is one of the Best 52-Week Low Penny Stocks to Buy Now. On August 8, UBS rais